Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-03-21
2006-03-21
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S025000, C514S053000, C514S054000, C514S057000, C514S060000, C536S001110, C536S004100, C536S056000, C536S058000, C536S063000, C536S068000, C536S102000, C536S107000, C536S115000, C536S119000
Reexamination Certificate
active
07015200
ABSTRACT:
The present invention provides compositions comprising at least one GHB moiety bonded to at least one physiologically compatible carrier molecule. The compositions can enhance the uptake of the drug, deliver effective therapeutic doses in a time-delayed fashion, or can target specific organs.
REFERENCES:
patent: 5753708 (1998-05-01), Koehler et al.
patent: 0442850 (1991-08-01), None
patent: WO-95/14476 (1995-06-01), None
Barrett et al, “Redox Glycosidation: A New Strategy for Disaccharide Synthesis”, J. Am. Chem. Soc., 1989, 111(4), pp. 1392-1396.
Bedard, M. A., “Nocturnal y-Hydroxybutyrate—Effect on Periodic Leg Movements and Sleep Organization of Narcoleptic Patients”,Clin Neuropharmacol. 12(1), (1989), 29-36.
Broughton, R., et al., “Effects of nocturnal gamma-hydroxybutyrate on sleep/waking patterns in narcolepsy-cataplexy”,Canadian Journal of Neurological Sciences, 7(1), (Feb. 1980), 23-31.
Gallimberti, L., et al., “Clinical efficacy of gamma-hydroxybutyric acid in treatment of opiate withdrawal”,Eur. Arch. Psychiatry Clin. Neurosci., 244(3), (1994), 113-114.
Gallimberti, L., “Gamma-Hydroxybutric Acid in the Treatment of Alcohol Dependence: A Double-Blind Study”,Alcohol Clin. Exp. Res., 16(4), (1992), 673-676.
Gallimberti, L., “Gamma-hydroxybutyric Acid for Treatment of Alcohol Withdrawal Syndrome”,Clinical Pharmacology, 2(8666), (1989), 787-789.
Gallimberti, L., et al., “Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome”,Neuropsychopharmacology, 9(1), (Aug. 1993),77-81.
Gerra, G., et al., “Flumazenil effects on growth hormone response to gamma-hydroxybutyric acid”,Int. Clin. Psychopharmacol., 9(3), (Sep. 1994), 211-215.
Gessa, G. L., “Gamma-hydroxybutyric Acid in the Treatment of Alcohol Dependence”,Clin. Neuropharm., 15 Suppl 1 Pt A, (1992), 303a-304a.
Grove-White, I. G., “Critical Flicker Frequency after Small Doses of Methohexitone, Diazepam and Sodium 4-Hydroxybutyrate”,Brit. J. Anaesth, 43(2), (1971), 110-112.
Hasenbos, M. A., “Anaesthesia for bullectomy. A technique with spontaneous ventilation and extradural blockade”,Anaesthesia, 40(10), (1985), 977-980.
Hoes, M. J., “Gamma-hydroxybutyric acid as hypnotic. Clinical and pharmacokinetic evaluation of gamma-hydroxybutyric acid as hypnotic in man”,Encephale, 6(1), (1980), 93-99.
Laborit, H., “Gamma-Hydroxybutyrate, Succinic Semialdehyde and Sleep”,Laboratoire d'Eutonologie, (1973), 257-274.
Ladinsky, Herbert, “Mode of Action of Gamma-Butyrolactone on the Central Cholinergic System”,Naunyn-Schmiedeberg's Arch. Pharmacol., 322, (1983), 42-48.
Lammers, G. J., “Gammahydroxybutyrate and Narcolepsy: A Double-Blind Placebo-Controlled Study”,Sleep, 16(3), (1993), 216-220.
Lapierre, O., “The Effect of Gamma-Hydroxybutyrate on Nocturnal and Diurnal Sleep of Normal Subjects: Further Considerations on REM Sleep-Triggering Mechanisms”,Sleep, 13, (1990), 24-30.
Lee, C. R., “Evidence for the B-Oxidation of Orally Administered 4-Hydroxybutyrate in Humans”,Biochemical Medicine, 17(3), (1977), 284-291.
Mamelak, M., et al., “Narcolepsy: a family study”,Biological Psychiatry, 14(5), (Oct. 1979), 821-834.
Mamelak, M., “Sleep-Inducing Effects of Gammahydroxybutyrate”,The Lancet, 2(7824), (1973), 328-329.
Mamelak, Mortimer., “The Effects of Gamma-Hydroxybutyrate on Sleep”,Biol. Psychiatry, 12(2), (1977), 273-288.
Oyama, T., et al., “Effects on neuroleptanaesthesia on plasma levels of growth hormone and insulin”,Br. J. Anaesth., 42(12), (Dec. 1970), 1105-1112.
Palatini, P., “Dose Dependent Absorption and Elimination of Gamma-Hydroxybutyric Acid in Healthy Volunteers”,Eur. J. Clin. Pharmacol., 45(4), (1993), 353-356.
Scharf, M. B., “Current Pharmacologic Management of Narcolepsy”,American Family Physician, 38(1), (Jul. 1988), 143-148.
Scharf, M. B., “The Effects and Effectiveness of y-Hydroxybutyrate in Patients with Narcolepsy”,J. Clin. Psychiatry, 46(6), (1985), 222-225.
Scrima, L., “The Effects of Y-Hydroxybutyrate on the Sleep of Narcolepsy Patients: A Double-Blind Study”,Sleep, 13(6), (1990), 479-490.
Series, F., “Effects of Enhancing Slow-Wave Sleep by Gamma-Hydroxybutyrate on Obsturctive Sleep Apnea”,Am. Rev. Respir. Dis., 145(6), (1992), 1378-1383.
Snead, O. C., “Ontogeny of Gamma-Hydroxybutyric Acid. Regional Concentratrion in Developing Rat, Monkey and Human Brain”,Brain Res., 227(4), (1981), 579-589.
Stock, G., “Increase in brain dopamine after axotomy or treatment with Gammahydroxybutyric acid due to elimination of the nerve impulse flow”,Naunyn-Schmiedeberg's Arch. Pharmacol., 278(4), (1973), 347-361.
Strong, A. J., “gamma-Hydroxybutyric acid and intracranial pressure”,The Lancet, 1(8389), (1984),1304.
Yamada, Y., “Effect of Butyrolactone and Gamma-Hydroxybutyrate on the EEG and Sleep Cycle in Man”,Electroenceph. clin. Neurophysiol., 22, (1967), 558-562.
Houghton William C.
Mamelak Mortimer
Miller Brian L.
Reardan Dayton T.
Orphan Medical, Inc.
Schwegman Lundberg Woessner & Kluth P.A.
White Everett
Wilson James O.
LandOfFree
Gamma-hydroxybutyrate compositions containing carbohydrate,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gamma-hydroxybutyrate compositions containing carbohydrate,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gamma-hydroxybutyrate compositions containing carbohydrate,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3614821